| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/03/2001 | CN1315855A Immediate release tablet |
| 10/03/2001 | CN1315853A Bioenhanced formulations comprising eprosartan in oral dosage form |
| 10/03/2001 | CN1315852A Medicinal aerosol formulations |
| 10/03/2001 | CN1315319A Process for preparing ethyl-sulfonylpiperidine derivatives |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297380 Process and intermediates for growth hormone secretagogues |
| 10/02/2001 | US6297375 4-phenyl-pyridine derivatives |
| 10/02/2001 | US6297371 Cytolysing raw cells, applying to anion exchanger which begins desorbing dna and rna at different ionic strengths, then eluting nucleic acids and/or oligonucleotides; treating preparation at first or last step to remove endotoxin |
| 10/02/2001 | US6297357 prb2/p130 peptide inhibitors of cdk2 kinase activity |
| 10/02/2001 | US6297282 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II |
| 10/02/2001 | US6297280 Theanine, and one or more compounds selected from the group consisting of cholines, arachidonic acid, eicoapentaenoic acid (epa) and docosahexaenoic acid (dha). |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 10/02/2001 | US6297267 Prostaglandin i2 agonist. |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 10/02/2001 | US6297264 E.g., 4-(2-benzyloxy-2-(3-cyclopentyloxy-4-methoxyphenyl)ethyl)pyrid ine; phosphodiesterase inhibitors |
| 10/02/2001 | US6297257 Benzazine derivatives phosphodiesterase 4 inhibitors |
| 10/02/2001 | US6297250 Useful for inhibiting transport of nucleosides or purines across cell membranes, thereby to potentiate the activity of various cytotoxic antitumor drugs |
| 10/02/2001 | US6297246 Benzoxazole derivatives; does not cause constipation as a side effect. |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments |
| 10/02/2001 | US6297226 Treating a disease or a condition in a mammal treatable by inhibiting the activity of a monoamine oxidase |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6297049 Methods and compositions for ameliorating the symptoms of sepsis |
| 10/02/2001 | US6297043 Molecular formula of c28 h20 o12; culture product from streptomyces which inhibits glucose-6-phosphate translocase; antidiabetic agents |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor |
| 10/02/2001 | US6297011 Mammalian tolloid-like gene and protein |
| 10/02/2001 | US6296878 Anti-inflammatory and anti-itching action, prevention and/or treatment of disorders of cardiovascular system, protective action against ultraviolet radiation, analgesic, promotive action on proliferation of fibroblasts, therapy of fire burn |
| 10/02/2001 | US6296856 Topically applying to the skin of such organism, a cutaneous aging-inhibitorycosmetic/pharmaceutical/dermatological composition suited to promote desquamation of mammalian skin and/or to stimulate epidermal renewal |
| 10/02/2001 | US6296853 For therapy of animal having a papilloma viral infection |
| 10/02/2001 | US6296848 GRB2 associating polypeptides and nucleic acids encoding therefor |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 10/02/2001 | CA2234567C Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| 10/02/2001 | CA2207835C New derivatives of 3-(piperid-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole, their preparation processes and the pharmaceutical compositions they contain |
| 10/02/2001 | CA2159626C Method for delivering beneficial compositions to hair follicles |
| 10/02/2001 | CA2054368C Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use |
| 10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 09/27/2001 | WO2001071358A1 Method of screening for inhibitors of osteopontin |
| 09/27/2001 | WO2001071342A2 Identification of mast cell/basophil activation inhibitors |
| 09/27/2001 | WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | WO2001071022A2 Lpa receptor agonists and antagonists and methods of use |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070975A1 Novel melanin concentrating hormone receptor |
| 09/27/2001 | WO2001070974A1 Novel protein, process for producing the same and use thereof |
| 09/27/2001 | WO2001070955A2 Identification of essential genes in prokaryotes |
| 09/27/2001 | WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | WO2001070742A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
| 09/27/2001 | WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/27/2001 | WO2001070740A1 Process for preparing crystalline form i of cabergoline |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070732A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070723A1 Benzothiophene derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 09/27/2001 | WO2001070701A1 5-hydroxy indazole derivatives for treating glaucoma |
| 09/27/2001 | WO2001070700A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/27/2001 | WO2001070698A1 Quinoline derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070696A1 Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070683A2 3-substituted-4-pyrimidone derivatives |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070672A2 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | WO2001070670A1 Novel phenylalanine derivative |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001070337A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
| 09/27/2001 | WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
| 09/27/2001 | WO2001070251A1 Anticancer compositions |
| 09/27/2001 | WO2001070249A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | WO2001070248A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |